does glp 1 speed up metabolism GLP-1-based therapies for type 2 diabetes: from single, dual and triple agonists to endogenous GLP-1 production and L-cell differentiation | Diabetology & Metabolic Syndrome Glucagon-like peptide-1 receptor: mechanisms and

This page contains key pharmaceutical news on drug recalls, FDA clearance, safety communications and research

From smaller portions to fewer take-out orders and an increase in protein-rich foods, weight-loss drugs are changing how Canadians eat

You may need more solid protein, more fiber, or a better meal structure earlier in the day

The dual GIP/GLP-1 receptor agonist tirzepatide is among the furthest developed multi-agonists for diabetes care and has so far displayed promising nephroprotective effects

Upper respiratory tract infections (URTIs) were the most frequently reported adverse event (8 of 12 reporting studies, 66.7%), occurring at rates comparable to controls across RCTs (GRADE: MODERATE certainty)